Pravastatin therapy and the risk of stroke

New England Journal of Medicine

Volumn 343, Issue 5, 2000, Pages 317-326

  White, Harvey D ^a   Simes, R John ^c   Anderson, Neil E ^b   Hankey, Graeme J ^d   Watson, John D G ^c   Hunt, David ^e   Colquhoun, David M ^f   Glasziou, Paul ^f   MacMahon, Stephen ^c   Kirby, Adrienne C ^c   West, Malcolm J ^f   Tonkin, Andrew M ^g  

^a GREEN LANE HOSPITAL   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c UNIVERSITY OF SYDNEY   (Australia)

^d ROYAL PERTH HOSPITAL   (Australia)

^e ROYAL MELBOURNE HOSPITAL   (Australia)

^f UNIVERSITY OF QUEENSLAND   (Australia)

^g NATIONAL HEART FOUNDATION OF AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; PLACEBO; PRAVASTATIN;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK MANAGEMENT; STROKE; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

ADULT; AGED; ANTICHOLESTEREMIC AGENTS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CORONARY DISEASE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PRAVASTATIN; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 0034601425     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200008033430502     Document Type: Article

References (42)

1. Mortality by cause for eight regions of the world: Global Burden of Disease Study
2. Blood pressure, cholesterol, and stroke in eastern Asia
3. American Heart Association Prevention Conference IV: Prevention and rehabilitation of stroke: Executive summary
4. Cholesterol, diastolic blood pressure, and stroke: 13,000 Strokes in 450,000 people in 45 prospective cohorts
5. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the Multiple Risk Factor Intervention Trial
6. An overview of trials of cholesterol lowering and risk of stroke
7. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
8. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS: Air Force/Texas Coronary Atherosclerosis Prevention Study
9. Effect of HMGcoA reductase inhibitors on stroke: A meta-analysis of randomized, controlled trials
10. Reduction of stroke incidence after myocardial infarction with pravastatin: The Cholesterol and Recurrent Events (CARE) study
11. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
12. Design features and baseline characteristics of the LIPID (Long-Term Intervention with Pravastatin in Ischemic Disease) Study: A randomized trial in patients with previous acute myocardial infarction and/or unstable angina pectoris
13. Prognosis and prognostic factors of retinal infarction: A prospective cohort study
14. Regression models and life-tables
15. Secondary prevention of vascular disease by prolonged antiplatelet treatment
16. Cholesterol lowering with statin drugs, risk of stroke, and total mortality: An overview of randomized trials
17. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
18. Effect of simvastatin on ischemic signs and symptoms in the Scandinavian Simvastatin Survival Study (4S)
19. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
20. Pravastatin, lipids, and atherosclerosis in the carotid arteries (PLAC-II)
21. Stroke, statins, and cholesterol: A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors
22. Outcome in patients with asymptomatic neck bruits
23. Proximal aortic atheroma: An independent risk factor for cerebral ischemia
24. Atherosclerotic plaque rupture in symptomatic carotid artery stenosis
25. Associations of lipoprotein cholesterols, apolipoproteins A-I and B, and triglycerides with carotid atherosclerosis and coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) Study
26. Precursors of extracranial carotid atherosclerosis in the Framingham Study
27. Beneficial effects of colestipol-niacin therapy on the common carotid artery: Two- and four-year reduction of intima-media thickness measured by ultrasound
28. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events
29. Kuopio Atherosclerosis Prevention Study (KAPS): A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries
30. Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic Mediterranean population: The Carotid Atherosclerosis Italian Ultrasound Study
31. Effect of lipid-lowering treatment on progression of atherosclerotic lesions - A duplex ultrasonographic investigation
32. Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: A randomized controlled clinical trial
33. Effects of lowering average or below-average cholesterol levels on the progression of carotid atherosclerosis: Results of the LIPID Atherosclerosis Substudy
34. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion
35. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease
36. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels
37. Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys
38. Hyperlipidemia and coronary disease: Correction of the increased thrombogenic potential with cholesterol reduction
39. Lifetime cost of stroke in the United States
40. Assessment and management of carotid disease